Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Financials
Pharma
Apellis stock price slid 10% despite 'robust' growth of Syfovre
Despite the expansion of Syfovre in geographic atrophy ahead of analysts' expectations, Apellis' stock price has dropped 30% so far this year.
Angus Liu
May 8, 2024 11:30am
Ennogen snares £30 million credit pact to fuel growth
May 8, 2024 9:10am
Madrigal builds launch infrastructure for MASH drug Rezdiffra
May 7, 2024 11:56am
Dupixent COPD delay possible, Eylea down 2%, Regeneron says
May 2, 2024 12:00pm
Samsung Biologics achieves record Q1 earnings
Apr 30, 2024 9:09am
Gilead writes $2.4B off Trodelvy as CEO underscores focus
Apr 26, 2024 11:21am